Jeddah Health Cluster 2 collaborates with Jamjoom Pharma to advance healthcare in Saudi Arabia

SAUDI ARABIA—Jeddah Health Cluster 2 has signed a cooperation agreement with Jamjoom Pharma to strengthen collaboration in healthcare, expand disease-awareness initiatives, and enhance the scientific knowledge of healthcare professionals across Saudi Arabia.

The partnership reflects a shared commitment to improving healthcare quality by promoting education, professional development, and evidence-based medical practice.

The agreement brings together Jeddah Health Cluster 2 and Jamjoom Pharma, one of Saudi Arabia’s leading pharmaceutical companies with a strong presence across the Middle East and Africa.

Through this collaboration, both organizations will work to improve patient care by supporting healthcare professionals with access to the latest medical knowledge and best practices.

Expanding healthcare education and professional development

Under the agreement, the two organisations will implement a range of educational and awareness programmes to improve public understanding of diseases and strengthen healthcare practitioners’ skills.

The initiative will include scientific meetings, specialised training programmes, educational workshops, and professional development activities covering various medical disciplines.

In addition, the partnership will facilitate the exchange of expertise between healthcare professionals and industry specialists.

By sharing scientific knowledge and practical experience, the organisations aim to promote the adoption of modern, evidence-based treatment approaches and improve the quality of healthcare services provided across the region.

Jeddah Health Cluster 2 stated that the agreement forms part of its broader strategy to strengthen partnerships with key stakeholders in the healthcare sector.

The Cluster also noted that closer collaboration with industry leaders will help develop national healthcare talent while supporting initiatives that deliver greater value to patients and communities.

Supporting strategic healthcare goals

The collaboration aligns with Jeddah Health Cluster 2’s strategic priorities: improving healthcare quality, empowering healthcare professionals, and expanding partnerships to contribute to sustainable health sector development.

Through continuous learning opportunities and knowledge sharing, the initiative seeks to equip healthcare workers with updated clinical information and practical skills that support better patient outcomes.

The agreement also supports the objectives of Saudi Vision 2030, which aims to transform the Kingdom’s healthcare sector by improving service quality, increasing operational efficiency, and enhancing residents’ overall quality of life.

Public and private sectors join forces

The agreement was signed by Dr Essam Gameel Al Sayed, General Manager for Consumer Health at Jamjoom Pharma, and Dr Shadi bin Salem Al Khayyat, Chief Executive Officer of Jeddah Health Cluster 2, during a ceremony attended by representatives from both organisations.

Commenting on the partnership, Dr Al Sayed said the agreement highlights the value of collaboration between the public and private sectors in strengthening health education and expanding medical knowledge.

He noted that combining expertise from both sectors will help accelerate the transfer of specialised knowledge, support healthcare professionals through continuous education, and encourage wider adoption of modern clinical practices.

He added that Jamjoom Pharma remains committed to expanding its contribution to healthcare and educational initiatives across Saudi Arabia by building long-term partnerships with healthcare institutions.

Through these collaborations, the company aims to support ongoing health sector development while creating effective models for cooperation between public healthcare providers and private industry.